Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Resectable NSCLC × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5696 Lung Neoplasms 3680 Small Cell Lung Carcinoma 1002 Breast Neoplasms 661 Neoplasms 614 Colorectal Neoplasms 547 Melanoma 474 Ovarian Neoplasms 431 Neoplasm Metastasis 428 Pancreatic Neoplasms 381 Stomach Neoplasms 330 Adenocarcinoma of Lung 308 Carcinoma, Renal Cell 306 Squamous Cell Carcinoma of Head and Neck 301 Head and Neck Neoplasms 291 Prostatic Neoplasms 284 Mesothelioma, Malignant 281 Esophageal Neoplasms 262 Mesothelioma 242 Colonic Neoplasms 224 Brain Neoplasms 215 Urinary Bladder Neoplasms 212 Triple Negative Breast Neoplasms 207 Uterine Cervical Neoplasms 204 Sarcoma 171 Endometrial Neoplasms 171 Carcinoma, Hepatocellular 155 NSCLC 133 Kidney Neoplasms 126 Carcinoma 126

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492342 2026-03-25

K-NADIR

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting

Resectable NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡